Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TADAFER IIb tadalafil for early-onset fetal growth restriction
jRCTs041190065Phase 2Completed
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tadalafil in intrauterine growth restriction (IUGR) (3 arms). Primary endpoint: Prolongation of gestational age at birth (days): placebo vs tadalafil 20 mg/day, placebo vs tadalafil 40 mg/day. Started Oct 2019; status: completed.
02
Drugs
tadalafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on jRCTs041190065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190065.